Glatiramer Acetate Powder CAS 147245-92-9 Glatiramer Acetate Materials Glatiramer Acetate Purity Peptides Glatiramer Acetate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• CAS: 147245-92-9
• Keyword: Glatiramer Acetate
• Keyword 1: Glatiramer Acetate Powder
• Transport Package: 1kg Foil Bag /25kg Drum
• Specification: 99%
• Trademark: /
• Origin: China
• Production Capacity: 20000

Product Description

Product Description

Description

Glatiramer acetate is animmunomodulator drug currently used to treat multiple sclerosis. Glatiramer acetate is a random polymer of four amino acids found inmyelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine, and may work as a decoy for the immune system. 
Although the clinical definition of multiple sclerosis requires two or more episodes of symptoms and signs, glatiramer acetate is approved for treatment after single episodes. Glatiramer acetate is also used to treat relapsing-remitting multiple sclerosis. Glatiramer acetate is administered by subcutaneous injection.

Product name	Glatiramer Acetate
Appearance	white Powder
Specification	99%
Shelf life	2 years when properly stored

Function and Application

Glatiramer acetate is approved for reducing the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that Glatiramer acetate may reduce progression of disability.